Access cutting-edge pulmonary arterial hypertension treatment through this clinical trial at a research site in San Francisco. Study-provided care at no cost to qualified participants.
Access pulmonary arterial hypertension specialists in San Francisco at no cost
This study follows strict safety protocols and ethical guidelines
All study-related pulmonary arterial hypertension treatment provided free
The purpose of the study is to learn how the study medicine called PF-07868489 is tolerated and acts in healthy adult people and people with pulmonary arterial hypertension (PAH). Part A: An investigator- and participant-blind, sponsor-open, placebo-controlled, single ascending dose study to assess the safety, tolerability, and pharmacokinetics (PK) of PF-07868489 in healthy adult participants. Part B: A 24-week, randomized, double blind, placebo-controlled study to assess the safety, tolera
Sponsor: Pfizer
Check if you qualify for this pulmonary arterial hypertension clinical trial in San Francisco, CA
If you're searching for pulmonary arterial hypertension treatment options in San Francisco, CA, this clinical trial may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our San Francisco research site is actively enrolling participants for this clinical trial. You'll receive care from experienced pulmonary arterial hypertension specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.